Media Trust Score90%

Clovis Oncology's Rubraca® (Rucaparib) as First-Line Maintenance Treatment … – The Facts

BOULDER, Colo.–(BUSINESS WIRE)–Sep 11, 2022–. Clovis Oncology, Inc. (NASDAQ: CLVS), today announced results from a subgroup analysis of data …

  • You already voted!
  • Read More